TAGAMET HB Rx-TO-OTC SWITCH HINGES ON OUTCOME OF DRUG INTERACTION STUDIES
This article was originally published in The Tan Sheet
Executive Summary
TAGAMET HB Rx-TO-OTC SWITCH HINGES ON OUTCOME OF DRUG INTERACTION STUDIES requested by FDA's Nonprescription Drugs and Gastrointestinal Drugs Advisory Committees at a joint meeting July 27-28. The panel was particularly interested in cimetidine's interaction with theophylline, an anti-asthma drug, and Upjohn's prescription sleep-aid Halcion (triazolam).